Innovate Next: A look into the future of healthcare

Our inaugural virtual summit brought together global leaders to discuss the critical issues and factors shaping healthcare in 2021.

Inaugural Event Highlights


Memorable moments from this extraordinary gathering.


Powerhouse Keynote Speakers


Two of the nation's most prominent public health policy experts address today's most critical challenges and compelling solutions.

Dr. Sanjay Gupta


The Emmy Award-winning CNN correspondent and neurosurgeon discussed COVID-19’s effect on remote working, the anti-vaxxer mindset and the confusing mix of research data and disinformation.

Sylvia Mathews Burwell


The president of American University and former U.S. Secretary of Health and Human Services called out hurdles to economic mobility in the US, how her teams stay motivated and today’s most important healthcare innovations.

Today’s vital topics and innovative ideas for tomorrow


Well-informed speakers and panelists weighed in on innovations in healthcare, medicine and investing, plus the challenges of managing the pandemic.

The Price Tag of Innovation


The panel featured Rishi Dalsania of Clearview Healthcare Partners and Harvard Pilgrim Healthcare’s Dr. Michael Sherman on drug pricing strategies and how the medical system will pay for therapies.

Healthcare Access: The Journey to 2025


Can the Affordable Care Act be improved? Is there a path to accessible healthcare for all? Will alternative care grow? The panel of industry and policy experts discussed the politics of healthcare.

The Evolution of Cross-Border Business


Brad Loncar, CEO of Loncar Investments, hosted a panel discussion with four pharmaceutical industry leaders about global market dynamics, trends in cross-border licensing and lessons from COVID-19.

Cognition: Next Frontier?


Cognition is a hot topic. UCSF’s Dr. Adam Gazzaley offered insights into the impact of the digital revolution in cognition, possibilities for therapy and non-drug digital solutions for treating ADHD.

Shaken & Stirred: Vaccine Reality


Can COVID-19 vaccines lead to an economic recovery? How widespread is vaccine hesitancy? Has the regulatory system changed in the race to develop them? The panelists shared their informed perspectives.

Pandemic Navigation & Building a Resilient Team


Group dynamics are crucial when a disaster such as the pandemic strikes. Johns Hopkins professor George Everly discussed how to build a resilient team, lead during crises and prepare for the future.

The Post-COVID-19 Environment


Stephanie Davis of SVB Leerink hosted a discussion on COVID-19’s long-term effect on healthcare and education and how the pace of change is likely to accelerate once we move beyond pandemic response mode.

Funding Window and Opportunistic Outlook


Cutting-edge startups keep launching in biotech and elsewhere. Threshold’s Emily Melton led a discussion about private and public funding, the long-term investor outlook and healthcare valuations.

The videos above including, without limitation, to the statistical information herein, is provided for informational purposes only. This video includes individuals and companies who are independent third parties and not affiliated with SVB Financial Group. Please see additional disclaimers below.

Highlights from Innovate Next


Deep dives, compelling conversations.
 

Is the Price Right?

 
For the first time in many years, it’s looking like reform measures, breakthrough pharma innovations and the COVID-19 crisis may finally be changing the drug pricing status quo.
 

Global Pandemic. International Collaboration.

 
The race to develop vaccines to fight COVID-19 seems to have shed new light on numerous advantages of cross-border cooperation for the industry and for its investor community.
 

Build A Team You Can Trust in Crunch Time

 
Success requires the coordinated effort of large numbers of people across multiple disciplines who can communicate well. Don’t wait for a crisis to start building a solid team.
 

The Window Is Wide Open

 
The IPO process may have changed, but by making a few, well-informed adjustments, opportunities abound for healthcare investors--now and for the foreseeable future.
 

Life After COVID-19

 
Change was constant even before COVID-19. Now, things are moving even faster. The question is, do we have the ability--and the agility--to respond quickly and effectively?
Our goal is to support by getting wind in the sails of the innovation ecosystem.
Katherine Andersen Head of Life Science & Healthcare Silicon Valley Bank Learn more
katherine andersen jelly bean

SVB’s Global Life Science & Healthcare Practice

 

Learn how SVB has been supporting healthcare companies and investors for decades.

Learn more

Healthcare Investment and Exits Annual Report 2021
 

Our annual update finds the healthcare sector performing exceptionally well amid the uncertainty of COVID-19. Get the data and SVB’s perspective in our report.

HCE Annual 2021 Report Cover 400x526
 
 
 

It’s not too early to start thinking about next year’s event

 

Keep connected for our 2022 Innovate Next event


© 2021 SVB Financial Group. All rights reserved. SVB, SVB FINANCIAL GROUP, SILICON VALLEY BANK, MAKE NEXT HAPPEN NOW and the chevron device are trademarks of SVB Financial Group, used under license. Silicon Valley Bank is a member of the FDIC and the Federal Reserve System. Silicon Valley Bank is the California bank subsidiary of SVB Financial Group (Nasdaq: SIVB).

© 2021 SVB Leerink LLC. All Rights Reserved. SVB Leerink LLC is a member of FINRA and SIPC. SVB Leerink LLC is a member of SVB Financial Group. Investment products and/or services offered by SVB Leerink LLC are not insured by the FDIC or any other federal government agency and are not guaranteed by Silicon Valley Bank or its affiliates. For disclosures specific to companies in the SVB Leerink Universe of Coverage, go to https://svbleerink.bluematrix.com/bluematrix/Disclosure2.

SPD, SHANGHAI PUDONG DEVELOPMENT BANK, and 浦发银行有限公司 are trademarks, separately and in combination, of Shanghai Pudong Development Bank, Ltd. in China, and are used under license. SPD Silicon Valley Bank is a Sino-U.S. joint-venture bank of Silicon Valley Bank, the California bank subsidiary and commercial banking operation of SVB Financial Group, and Shanghai Pudong Development Bank.

Silicon Valley Bank is registered in England and Wales at Alphabeta, 14-18 Finsbury Square, London EC2A 1BR, UK under No. FC029579. Silicon Valley Bank is authorized and regulated by the California Department of Financial Protection and Innovation and the United States Federal Reserve Bank; authorized by the Prudential Regulation Authority with number 577295; and subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of our regulation by the Prudential Regulation Authority are available from us on request.

Silicon Valley Bank, a public corporation with limited liability (Aktiengesellschaft) under the laws of the U.S. federal state of California, with registered office in Santa Clara, California, U.S.A. is registered with the California Secretary of State under No. C1175907, Chief Executive Officer (Vorstand): Gregory W. Becker, Chairman of the Board of Directors (Aufsichtsratsvorsitzender): Roger F. Dunbar. Silicon Valley Bank Germany Branch is a branch of Silicon Valley Bank. Silicon Valley Bank Germany Branch with registered office in Frankfurt am Main is registered with the local court of Frankfurt am Main under No. HRB 112038, Branch Directors (Geschäftsleiter): Oscar C. Jazdowski, John K. Peck. Competent Supervisory Authority: Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin), Graurheindorfer Straße 108, 53117 Bonn, Germany.

Silicon Valley Bank and SVB Financial Group UK Limited are not licensed in Ireland to undertake banking business in Ireland or to undertake any other regulated activity in Ireland.

Silicon Valley Bank is not licensed to undertake banking business in Denmark or to undertake any other regulated activity in Denmark.

SVB Israel Advisors Ltd. is a subsidiary of SVB Financial Group. Neither SVB Israel Advisors nor SVB Financial Group is licensed to conduct banking business or provide other financial services in Israel and neither engages in unlicensed banking activities. Banking services are provided by Silicon Valley Bank, a member of FDIC. Silicon Valley Bank is not supervised by the Supervisor of Banks in the Bank of Israel but by the US Federal Reserve Bank and the California Department of Financial Protection and Innovation (DFPI).

Silicon Valley Bank, an authorized foreign bank branch under the Bank Act (Canada).